United Therapeutics Corporation Reports Second Quarter 2013 Financial Results

Published: Jul 25, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SILVER SPRING, Md., July 25, 2013 -- SILVER SPRING, Md., July 25, 2013 /PRNewswire/ --
  • Total Revenues of $280.6 million

  • Earnings per Share of $1.60 per Basic Share or $1.52 per Diluted Share

  • Earnings Before Non-Cash Charges of $3.29 per Basic Share, or $3.11 per Diluted Share

Help employers find you! Check out all the jobs and post your resume.

Back to news